F. Dreyfus

2.2k total citations
56 papers, 1.2k citations indexed

About

F. Dreyfus is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, F. Dreyfus has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 20 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in F. Dreyfus's work include Acute Myeloid Leukemia Research (26 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Multiple Myeloma Research and Treatments (8 papers). F. Dreyfus is often cited by papers focused on Acute Myeloid Leukemia Research (26 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Multiple Myeloma Research and Treatments (8 papers). F. Dreyfus collaborates with scholars based in France, United Kingdom and United States. F. Dreyfus's co-authors include Prin L, Bernd Groner, Isabelle Dusanter‐Fourt, R Weber-Nordt, J Delobel, Fabrice Gouilleux, Corinne Desaint, Valérie Gouilleux‐Gruart, Didier Bouscary and Pierre Fenaux and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

F. Dreyfus

54 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Dreyfus France 15 645 462 441 326 256 56 1.2k
Yoshihiro Kameoka Japan 17 294 0.5× 563 1.2× 330 0.7× 270 0.8× 220 0.9× 64 1.3k
Lene Meldgaard Knudsen Denmark 23 1.1k 1.8× 989 2.1× 782 1.8× 200 0.6× 430 1.7× 50 1.9k
Krzysztof Jamroziak Poland 20 277 0.4× 357 0.8× 493 1.1× 473 1.5× 204 0.8× 106 1.1k
JL Harousseau France 19 895 1.4× 594 1.3× 675 1.5× 215 0.7× 142 0.6× 24 1.4k
Michal Bar‐Natan United States 15 719 1.1× 524 1.1× 312 0.7× 364 1.1× 157 0.6× 41 1.3k
Lia Perez United States 22 940 1.5× 322 0.7× 441 1.0× 179 0.5× 277 1.1× 80 1.3k
Ugo Consoli Italy 17 257 0.4× 367 0.8× 395 0.9× 181 0.6× 239 0.9× 36 863
Anuj Mahindra United States 17 918 1.4× 703 1.5× 477 1.1× 227 0.7× 116 0.5× 56 1.2k
Yosuke Minami Japan 22 812 1.3× 802 1.7× 395 0.9× 355 1.1× 287 1.1× 103 1.6k
Ravindran Ankathil Malaysia 22 225 0.3× 649 1.4× 318 0.7× 174 0.5× 92 0.4× 99 1.3k

Countries citing papers authored by F. Dreyfus

Since Specialization
Citations

This map shows the geographic impact of F. Dreyfus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Dreyfus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Dreyfus more than expected).

Fields of papers citing papers by F. Dreyfus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Dreyfus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Dreyfus. The network helps show where F. Dreyfus may publish in the future.

Co-authorship network of co-authors of F. Dreyfus

This figure shows the co-authorship network connecting the top 25 collaborators of F. Dreyfus. A scholar is included among the top collaborators of F. Dreyfus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Dreyfus. F. Dreyfus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dreyfus, F., et al.. (2025). Imagerie des urgences absolues et relatives en neuro-ophtalmologie. 44(3). 1–20.
2.
Rosé, Christian, Olivier Fitoussi, Emmanuel Gyan, et al.. (2016). Prospective Evaluation of the Effect of Deferasirox on Hematologic Response in Transfusion-Dependent Patients with Low-Risk MDS and Iron Overload: The Rythmex Study. Blood. 128(22). 2008–2008. 7 indexed citations
4.
Adès, Lionel, Mikkael A. Sekeres, Alice Wolfromm, et al.. (2013). Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine. Leukemia Research. 37(6). 609–613. 80 indexed citations
5.
Vergez, François, Alexa S. Green, Jérôme Tamburini, et al.. (2011). High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study. Haematologica. 96(12). 1792–1798. 147 indexed citations
6.
Kelaïdi, Charikleia, Aspasia Stamatoullas, Odile Beyne‐Rauzy, et al.. (2009). Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myelodysplasies. Haematologica. 95(6). 892–899. 13 indexed citations
7.
Mannone, Lionel, Claude Gardin, Jérôme Bernard, et al.. (2006). High‐dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study. British Journal of Haematology. 133(5). 513–519. 72 indexed citations
8.
Ducastelle, Sophie, Lionel Adès, Claude Gardin, et al.. (2006). Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.. PubMed. 91(3). 373–6. 9 indexed citations
10.
Park, Sophie, S. Abad, M Tulliez, et al.. (2004). Pseudouveitis. Medicine. 83(4). 223–232. 14 indexed citations
11.
Duprez, V, et al.. (2001). Thrombopoietin stimulates cortactin translocation to the cytoskeleton independently of tyrosine phosphorylation. Biochemical Journal. 356(3). 875–875. 4 indexed citations
12.
Zompì, Simona, O. Legrand, Didier Bouscary, et al.. (2000). Therapy‐related acute myeloid leukaemia after successful therapy for acute promyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature. British Journal of Haematology. 110(3). 610–613. 25 indexed citations
13.
Bouscary, Didier, C. Ginsburg, Pierre Palmer, et al.. (1998). [Acyclovir-resistance zona in a immunocompromised HIV seronegative patient].. PubMed. 125(2). 127–8. 1 indexed citations
14.
Fermand, Jean‐Paul, Philippe Ravaud, Sylvie Chevret, et al.. (1996). High-dose therapy and autologous blood stem cell transplantation in multiple myeloma: Preliminary results of a randomized trial involving 167 patients. Stem Cells. 13(S2). 156–159. 13 indexed citations
15.
Bourquelot, Priscille, Didier Bouscary, Françoise Picard, et al.. (1996). Hemophagocytic Syndrome Associated with Bacteroides Fragilis Infection in a Patient with Acute Monoblastic Leukemia. Leukemia & lymphoma. 22(1-2). 177–179. 1 indexed citations
16.
Viguié, F, Yann Prigent, Sylvie Ramond, et al.. (1995). Fluorescence in situ hybridization analysis of minute marker chromosomes in leukemia with monosomy 7.. PubMed. 9(7). 1154–8. 9 indexed citations
17.
Bouscary, Didier, M Tulliez, F. Dreyfus, et al.. (1995). Polymyositis Associated with Ki-1 Lymphoma. Leukemia & lymphoma. 17(1-2). 185–188. 3 indexed citations
18.
Blanche, P., et al.. (1995). Scleroderma, polymyositis, and hairy cell leukemia.. PubMed. 22(7). 1384–5. 10 indexed citations
19.
Dreyfus, F., et al.. (1994). Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics. Clinical Pharmacology & Therapeutics. 55(6). 649–660. 92 indexed citations
20.
Fichelson, Serge, F. Dreyfus, Roland Berger, et al.. (1992). Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosomal region.. PubMed. 6(2). 93–9. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026